See
Genome Information for Homo sapiens
Robust, efficient, and reliable testing for SARS-CoV-2 is extraordinarily challenging due to our lack of ultra-sensitive assays and constantly evolving knowledge of the virus. Standard PCR based assays still result in very high false negative rates in the earliest days of infection. Microfluidic processing of clinical samples is low cost and shows great promise for translating most liquid biopsy assays to the clinic. Our laboratory was one of the first to apply microfluidic technologies for the isolation of both circulating tumor cells and exosomes in the blood of patients with cancer. For SARS-CoV-2 patients, saliva, stool, and plasma are all thought to be potential resources for both virus detection, as well as other clinical biomarkers that might inform us of infection. Thus, we seek... (for more see dbGaP study page.)
| Accession | PRJNA799434; dbGaP: phs002778 |
| Type | Umbrella project (Subtype:Authorized Access) |
| Organism | Homo sapiens[Taxonomy ID: 9606] Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo; Homo sapiens |
| Submission | Registration date: 21-Jan-2022
OD |
| Relevance | Medical |
Project Data:
| Resource Name | Number
of Links |
|---|
| Genotype and Phenotype (dbGaP) | 1 |
Rapid Acceleration of Diagnostics - Radical (RADx-rad): Microfluidic Isolation and Characterization of SARS-CoV-2 and Virus Related Exosomes encompasses the following sub-project:
| Project Type | Number of Projects |
| Phenotype or Genotype | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA799435 | Homo sapiens | Rapid Acceleration of Diagnostics - Radical (RADx-rad): Microfluidic Isolation and Characterization of SARS-CoV-2 and Virus Related Exosomes (MASSACHUSETTS GENERAL HOSPITAL) |
|